Loading…
Next Generation Hispanic-Serving Institutions Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2010 · first_quarter · Medicare/Medicaid
H.R. 1458/S. 565 - Comprehensive Immunosuppresive Drug Coverage for Kidney Transplant Patients Act of 2007 - Lobbied to provide longer payment periods for immunosuppresive drugs. H.R. 684 and S. 330 - Medicare Prescription Drug Savings and Choice Act - Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254 - The Medicare Home Infusion Therapy Coverage Act - Lobbied to improve reimbursements for Medicare home infusion therapy. No Bill - Medicare Part D Oversight - Lobbied to educate on the benefits of private negotiation in Medicare Part D.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,060,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Medicare/Medicaid
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bills. S. 547, Drug Rebate Equalization Act of 2009. Lobbied against extending the Medicaid rebate to managed care organizations H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574/ S. 254, Medicare Home Infusion Therapy Coverage Act of 2009. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied in support of early treatment of HIV/AIDS.
Client expense: $952,580 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2009 · second_quarter · Medicare/Medicaid
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. H.R. 1616, Early Treatment of HIV/AIDS. Lobbied members of Congress in support of early treatment of HIV/AIDS. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, Medicare Home Infusion Therapy Coverage Act.Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations.
Client expense: $809,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Medicare/Medicaid
NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D. S. 547, Drug Rebate Equalization Act. Lobbied against extending the Medicaid rebate to managed care organizations. H.R. 684 and S. 330, Medicare Prescription Drug Savings and Choice Act. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. H.R. 574 and S. 254, the Medicare Home Infusion Therapy Coverage Act. Lobbied for passage of the bill. H.R.1458/ S.565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007. Lobbied for passage of bills. H.R. 684/ S. 330, Medicare Prescription Drug Savings and Choice Act of 2009. Lobbied against establishing a government sponsored fall-back plan in Medicare Part D. 4S. 301, Physician Payments Sunshine Act of 2009. Lobbied to ensure access to prescription drugs.
Client expense: $814,676 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Medicare/Medicaid
Obtain cosponsorship and passage of Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2008 (HR 1458 , S. 565) as related to PKD.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
| Democratic |
| NY |
| John Cornyn | Republican | TX |
| Kay Bailey Hutchison | Republican | TX |
| Ken Salazar | Democratic | CO |
| Mel Martinez | Republican | FL |